In this single-center retrospective study, all patients received immunotherapy before surgery. After surgery, more than 40% of the patients achieved pCR, with 66.7% and 29.8% of patients with dMMR and pMMR colorectal cancer achieving pCR,…
Neoadjuvant combination immunotherapy for colorectal cancer: clinical and molecular predictors of pathological complete response and safety assessment | BMC Gastroenterology
